Cargando…

Serum Cytokeratin 18 M30 Levels in Chronic Hepatitis B Reflect Both Phase and Histological Activities of Disease

Chronic hepatitis B has highly a dynamic course with significant fluctuations of HBV-DNA and ALT impeding assessment of disease activity. New biomarkers of inflammatory versus noninflammatory stages of HBV infection are urgently needed. Cytokeratin 18 epitope M30 (M30 CK-18) is a sensitive marker of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Świderska, Magdalena, Jaroszewicz, Jerzy, Parfieniuk-Kowerda, Anna, Rogalska-Płońska, Magdalena, Stawicka, Agnieszka, Panasiuk, Anatol, Flisiak, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554581/ https://www.ncbi.nlm.nih.gov/pubmed/28827897 http://dx.doi.org/10.1155/2017/3480234

Ejemplares similares

The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease
por: Świderska, Magdalena, et al.
Publicado: (2017)

Chronic hepatitis B virus infection is associated with decreased serum 25(OH)D concentration in non-cirrhotic patients
por: Parfieniuk-Kowerda, Anna, et al.
Publicado: (2019)

The occurrence of autoantibodies in patients with chronic HCV infection, including patients dialyzed and after kidney transplantation
por: Łapiński, Tadeusz W., et al.
Publicado: (2016)

Immune regulation and viral diversity as correlates of natural and treatment induced immune control in persistent hepatitis B virus (HBV) infection
por: Parfieniuk-Kowerda, Anna, et al.
Publicado: (2015)

The Role of Th17 Response in COVID-19
por: Martonik, Diana, et al.
Publicado: (2021)

Shear-wave elastography for evaluation of hepatic stiffness in chronic viral hepatitis B and C
por: Martonik, Diana, et al.
Publicado: (2023)

Impact of rs12979860 polymorphism on liver morphology in chronic HCV infection
por: Łapiński, Tadeusz Wojciech, et al.
Publicado: (2015)

High prevalence of anti-HEV antibodies among patients with immunosuppression and hepatic disorders in eastern Poland
por: Parfieniuk-Kowerda, Anna, et al.
Publicado: (2018)

Clinical Usefulness of the Inhibitory Control Test (ICT) in the Diagnosis of Minimal Hepatic Encephalopathy
por: Stawicka, Agnieszka, et al.
Publicado: (2020)

Brain-derived neurotrophic factor as a potential diagnostic marker in minimal hepatic encephalopathy
por: Stawicka, Agnieszka, et al.
Publicado: (2021)

Normalizing serum hepcidin but not α-1-antitrypsin level during effective treatment of chronic hepatitis C
por: Rogalska-Taranta, Magdalena, et al.
Publicado: (2017)

Effect of psoriasis activity on serum adiponectin and leptin levels
por: Baran, Anna, et al.
Publicado: (2015)

Hyaluronic acid concentration in liver diseases
por: Gudowska, Monika, et al.
Publicado: (2015)

High serum N-terminal propeptide of procollagen type III concentration is associated with liver diseases
por: Gudowska, Monika, et al.
Publicado: (2017)

Real-World Effectiveness and Safety of Direct-Acting Antivirals in Patients with Chronic Hepatitis C and Epilepsy: An Epi-Ter-2 Study in Poland
por: Pazgan-Simon, Monika, et al.
Publicado: (2023)

Plasma Cytokeratin-18 Fragment Level Reflects the Metabolic Phenotype in Obesity
por: Goralska, Joanna, et al.
Publicado: (2023)

Pangenotypic triple versus double therapy in HCV-infected patients after prior failure of direct-acting antivirals
por: Flisiak, Robert, et al.
Publicado: (2023)

Effect of antiviral and immunomodulatory treatment on a cytokine profile in patients with COVID-19
por: Martonik, Diana, et al.
Publicado: (2023)

A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis
por: Eguchi, Akiko, et al.
Publicado: (2022)

Effect of COVID-19 on Anti-S Antibody Response in Healthcare Workers Six Months Post-Vaccination
por: Flisiak, Robert, et al.
Publicado: (2021)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

Simple non-invasive markers for early diagnosis and determination of the severity of liver diseases
por: Gudowska, Monika, et al.
Publicado: (2016)

Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens
por: Tronina, Olga, et al.
Publicado: (2023)

Total and Free Serum Sialic Acid Concentration in Liver Diseases
por: Gruszewska, Ewa, et al.
Publicado: (2014)

The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins
por: Chrostek, Lech, et al.
Publicado: (2013)

Change in the Clinical Picture of Hospitalized Patients with COVID-19 between the Early and Late Period of Dominance of the Omicron SARS-CoV-2 Variant
por: Flisiak, Robert, et al.
Publicado: (2023)

Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis
por: Baran, Anna, et al.
Publicado: (2019)

Serum and urine periostin and cytokeratin-18 in children with congenital obstructive nephropathy
por: Turczyn, Agnieszka, et al.
Publicado: (2022)

Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings
por: Dobrowolska, Krystyna, et al.
Publicado: (2023)

Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance
por: Flisiak, Robert, et al.
Publicado: (2022)

Correction: Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance
por: Flisiak, Robert, et al.
Publicado: (2022)

The Significance of Caspase-Cleaved Cytokeratin 18 in Pleural Effusion
por: Lee, Keu Sung, et al.
Publicado: (2014)

Serum Cytokeratin-18 Levels for Liver Fibrosis Prediction
por: Caviglia, Gian Paolo, et al.
Publicado: (2015)

Cytokeratin-18 in Diagnosis of HCC in Patients with Liver Cirrhosis
por: Ismail, Saber A, et al.
Publicado: (2017)

Distribution of HBV genotypes in Poland
por: Świderska, Magdalena, et al.
Publicado: (2015)

Cytokeratins in gastroenterology. Systematic review
por: Pastuszak, Marek, et al.
Publicado: (2015)

Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database
por: Flisiak, Robert, et al.
Publicado: (2023)

An analysis of Cyclin D1, Cytokeratin 5/6 and Cytokeratin 8/18 expression in breast papillomas and papillary carcinomas
por: Wang, Yu, et al.
Publicado: (2013)

Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2021)

Prevalence and Risk Factors of HCV/HIV Co-Infection and HCV Genotype Distribution in North-Eastern Poland
por: Grzeszczuk, Anna, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n1lg3tt6salqpf5hl50hm1jitj